| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | 13.5 | 2744.5 | 365.0 | 4.0 | - | - | 3127 |
| 1 | - | - | - | - | - | 41.0 | 7.0 | - | - | - | 48 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 4 |
| 1 | 2 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 220 |
| 1 | 944 |
Number of post synapses: 6254
Number of pre synapses: 96
Number of output connections: 213
Coverage factor: 1.1
Columnar completeness: 0.50
Area completeness: 0.60
Cell size (columns): 146
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
| instance | NT | total connections | connections /#MeVP59 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | MeTu1 (R) | ACh | 2,074 | 1,037.0 | 33.5% | 33.5% |
| 1 | Dm2 (R) | ACh | 1,198 | 599.0 | 19.3% | 52.8% |
| 2 | Cm3 (R) | GABA | 476 | 238.0 | 7.7% | 60.5% |
| 3 | MeVPMe5 (L) | Glu | 428 | 214.0 | 6.9% | 67.4% |
| 4 | Cm9 (R) | Glu | 380 | 190.0 | 6.1% | 73.5% |
| 5 | MeVP6 (R) | Glu | 193 | 96.5 | 3.1% | 76.6% |
| 6 | MeVP45 (R) | ACh | 183 | 91.5 | 3.0% | 79.6% |
| 7 | Cm21 (R) | GABA | 151 | 75.5 | 2.4% | 82.0% |
| 8 | Cm30 (R) | GABA | 134 | 67.0 | 2.2% | 84.2% |
| 9 | MeVP9 (R) | ACh | 66 | 33.0 | 1.1% | 85.2% |
| 10 | MeVPMe4 (L) | Glu | 57 | 28.5 | 0.9% | 86.1% |
| 11 | Tm5c (R) | Glu | 57 | 28.5 | 0.9% | 87.1% |
| 12 | MeTu4c (R) | ACh | 54 | 27.0 | 0.9% | 87.9% |
| 13 | MeVP33 (R) | ACh | 52 | 26.0 | 0.8% | 88.8% |
| 14 | Dm8a (R) | Glu | 51 | 25.5 | 0.8% | 89.6% |
| 15 | MeVP42 (R) | ACh | 43 | 21.5 | 0.7% | 90.3% |
| 16 | aMe26 (R) | ACh | 41 | 20.5 | 0.7% | 91.0% |
| 17 | MeTu4a (R) | ACh | 40 | 20.0 | 0.6% | 91.6% |
| 18 | Mi15 (R) | ACh | 38 | 19.0 | 0.6% | 92.2% |
| 19 | MeTu3c (R) | ACh | 31 | 15.5 | 0.5% | 92.7% |
| 20 | Cm5 (R) | GABA | 30 | 15.0 | 0.5% | 93.2% |
| 21 | MeLo3b (R) | ACh | 30 | 15.0 | 0.5% | 93.7% |
| 22 | Cm1 (R) | ACh | 27 | 13.5 | 0.4% | 94.1% |
| 23 | MeTu3b (R) | ACh | 24 | 12.0 | 0.4% | 94.5% |
| 24 | MeVPMe6 (L) | Glu | 23 | 11.5 | 0.4% | 94.9% |
| 25 | Cm17 (R) | GABA | 19 | 9.5 | 0.3% | 95.2% |
| 26 | Cm10 (R) | GABA | 17 | 8.5 | 0.3% | 95.5% |
| 27 | MeTu4f (R) | ACh | 16 | 8.0 | 0.3% | 95.7% |
| 28 | MeVC2 (L) | ACh | 13 | 6.5 | 0.2% | 95.9% |
| 29 | Cm2 (R) | ACh | 11 | 5.5 | 0.2% | 96.1% |
| 30 | MeLo4 (R) | ACh | 11 | 5.5 | 0.2% | 96.3% |
| 31 | MeVPMe11 (L) | Glu | 11 | 5.5 | 0.2% | 96.5% |
| 32 | MeVPMe8 (R) | Glu | 11 | 5.5 | 0.2% | 96.6% |
| 33 | Cm11d (R) | ACh | 10 | 5.0 | 0.2% | 96.8% |
| 34 | Cm25 (R) | Glu | 10 | 5.0 | 0.2% | 97.0% |
| 35 | MeLo6 (R) | ACh | 9 | 4.5 | 0.1% | 97.1% |
| 36 | Mi10 (R) | ACh | 9 | 4.5 | 0.1% | 97.2% |
| 37 | OA-AL2i4 (R) | OA | 9 | 4.5 | 0.1% | 97.4% |
| 38 | Cm20 (R) | GABA | 8 | 4.0 | 0.1% | 97.5% |
| 39 | MeVC8 (L) | ACh | 8 | 4.0 | 0.1% | 97.6% |
| 40 | Cm12 (R) | GABA | 7 | 3.5 | 0.1% | 97.8% |
| 41 | Lat3 (R) | unclear | 7 | 3.5 | 0.1% | 97.9% |
| 42 | MeVC7a (L) | ACh | 7 | 3.5 | 0.1% | 98.0% |
| 43 | MeVP8 (R) | ACh | 7 | 3.5 | 0.1% | 98.1% |
| 44 | Dm-DRA1 (R) | Glu | 6 | 3.0 | 0.1% | 98.2% |
| 45 | MeVP21 (R) | ACh | 6 | 3.0 | 0.1% | 98.3% |
| 46 | aMe9 (R) | ACh | 5 | 2.5 | 0.1% | 98.4% |
| 47 | Cm23 (R) | Glu | 5 | 2.5 | 0.1% | 98.5% |
| 48 | Cm4 (R) | Glu | 5 | 2.5 | 0.1% | 98.5% |
| 49 | Cm19 (R) | GABA | 4 | 2.0 | 0.1% | 98.6% |
| 50 | Cm29 (R) | GABA | 4 | 2.0 | 0.1% | 98.7% |
| 51 | Cm8 (R) | GABA | 4 | 2.0 | 0.1% | 98.7% |
| 52 | MeVP7 (R) | ACh | 4 | 2.0 | 0.1% | 98.8% |
| 53 | MeVPMe3 (L) | Glu | 4 | 2.0 | 0.1% | 98.9% |
| 54 | TmY10 (R) | ACh | 4 | 2.0 | 0.1% | 98.9% |
| 55 | aMe17a (R) | Glu | 3 | 1.5 | 0.0% | 99.0% |
| 56 | Cm33 (R) | GABA | 3 | 1.5 | 0.0% | 99.0% |
| 57 | MeVP40 (R) | unclear | 3 | 1.5 | 0.0% | 99.1% |
| 58 | MeVPLo2 (R) | ACh | 3 | 1.5 | 0.0% | 99.1% |
| 59 | MeVPMe9 (L) | Glu | 3 | 1.5 | 0.0% | 99.2% |
| 60 | Tm29 (R) | Glu | 3 | 1.5 | 0.0% | 99.2% |
| 61 | aMe17e (R) | Glu | 2 | 1.0 | 0.0% | 99.2% |
| 62 | aMe6b (R) | ACh | 2 | 1.0 | 0.0% | 99.3% |
| 63 | Cm27 (R) | Glu | 2 | 1.0 | 0.0% | 99.3% |
| 64 | Dm8b (R) | Glu | 2 | 1.0 | 0.0% | 99.3% |
| 65 | MeTu4d (R) | ACh | 2 | 1.0 | 0.0% | 99.4% |
| 66 | MeVC22 (R) | Glu | 2 | 1.0 | 0.0% | 99.4% |
| 67 | MeVC5 (L) | ACh | 2 | 1.0 | 0.0% | 99.4% |
| 68 | Tm34 (R) | Glu | 2 | 1.0 | 0.0% | 99.5% |
| 69 | Tm37 (R) | Glu | 2 | 1.0 | 0.0% | 99.5% |
| instance | NT | total connections | connections /#MeVP59 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Cm3 (R) | GABA | 33 | 16.5 | 14.7% | 14.7% |
| 1 | Cm6 (R) | GABA | 29 | 14.5 | 12.9% | 27.6% |
| 2 | Cm8 (R) | GABA | 27 | 13.5 | 12.0% | 39.6% |
| 3 | MeVPMe5 (R) | Glu | 16 | 8.0 | 7.1% | 46.7% |
| 4 | MeVPMe9 (R) | Glu | 14 | 7.0 | 6.2% | 52.9% |
| 5 | MeVPMe4 (R) | Glu | 9 | 4.5 | 4.0% | 56.9% |
| 6 | Tm37 (R) | Glu | 9 | 4.5 | 4.0% | 60.9% |
| 7 | Cm12 (R) | GABA | 8 | 4.0 | 3.6% | 64.4% |
| 8 | Cm5 (R) | GABA | 7 | 3.5 | 3.1% | 67.6% |
| 9 | MeVP7 (R) | ACh | 7 | 3.5 | 3.1% | 70.7% |
| 10 | Cm24 (R) | Glu | 6 | 3.0 | 2.7% | 73.3% |
| 11 | MeTu1 (R) | ACh | 4 | 2.0 | 1.8% | 75.1% |
| 12 | aMe5 (R) | ACh | 3 | 1.5 | 1.3% | 76.4% |
| 13 | Cm16 (R) | Glu | 3 | 1.5 | 1.3% | 77.8% |
| 14 | Cm21 (R) | GABA | 3 | 1.5 | 1.3% | 79.1% |
| 15 | Cm9 (R) | Glu | 3 | 1.5 | 1.3% | 80.4% |
| 16 | Cm20 (R) | GABA | 2 | 1.0 | 0.9% | 81.3% |
| 17 | Cm31b (R) | GABA | 2 | 1.0 | 0.9% | 82.2% |
| 18 | Dm2 (R) | ACh | 2 | 1.0 | 0.9% | 83.1% |
| 19 | MeVP11 (R) | ACh | 2 | 1.0 | 0.9% | 84.0% |
| 20 | MeVP6 (R) | Glu | 2 | 1.0 | 0.9% | 84.9% |
| 21 | Mi15 (R) | ACh | 2 | 1.0 | 0.9% | 85.8% |